華潤醫藥(03320.HK)與華潤租賃訂立2020年戰略合作協議
格隆匯12月9日丨華潤醫藥(03320.HK)發佈公告,由於2017年華潤租賃戰略合作協議的補充協議及其項下的年度上限將於2019年12月31日到期,公司於2019年12月9日與華潤租賃訂立2020年戰略合作協議,期限為自2020年1月1日起計至2020年12月31日止。
根據協議,集團可使用華潤租賃提供的金融服務及產品,包括(但不限於)融資租賃、租賃及相關顧問及擔保服務,以及有關集團主要業務的保理。
公告表示,2020年戰略合作協議將使集團加強其整體流動資金,優化利用現金及資本,以及提高集團的現金及資本管理靈活性以產生更佳回報,並從中受益。根據2020年戰略合作協議,集團毋須獨家使用由華潤租賃提供的金融服務及產品。董事會認為,集團將可於計及其業務需求以及所提供服務及產品的費用及質素後,靈活及酌情選擇華潤租賃及╱或其他獨立金融機構或商業銀行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.